Cibc Private Wealth Group, LLC Elevation Oncology, Inc. Transaction History
Cibc Private Wealth Group, LLC
- $51.3 Billion
- Q1 2025
A detailed history of Cibc Private Wealth Group, LLC transactions in Elevation Oncology, Inc. stock. As of the latest transaction made, Cibc Private Wealth Group, LLC holds 160,530 shares of ELEV stock, worth $57,790. This represents 0.0% of its overall portfolio holdings.
Number of Shares
160,530Holding current value
$57,790% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding ELEV
# of Institutions
6Shares Held
2.84MCall Options Held
0Put Options Held
0-
Black Rock Inc. New York, NY2.49MShares$896,4890.0% of portfolio
-
Nuveen Asset Management, LLC Chicago, IL174KShares$62,6890.0% of portfolio
-
Fny Investment Advisers, LLC10KShares$3,6000.0% of portfolio
-
Advisor Group Holdings, Inc. Phoenix, AZ2KShares$7200.0% of portfolio
-
Concourse Financial Group Securities, Inc. Birmingham, AL0Shares$0100.0% of portfolio
About Elevation Oncology, Inc.
- Ticker ELEV
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 23,300,900
- Market Cap $8.39M
- Description
- Elevation Oncology, Inc., a clinical-stage biopharmaceutical company, focuses on developing therapeutics for the treatment of cancer in genomically defined patient populations in the United States. The company's lead program is the seribantumab, an anti-HER3 monoclonal antibody that is in Phase II CRESTONE trial for the treatment of advanced sol...